Skip to Content
  1. All products
  2. Biosimilar Antibodies
  3. Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody
  4. Biosimilar Antibodies
Pricelist: Default EUR pricelist Pricelist
Pricelist: Default EUR pricelist Pricelist
Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

(0 review)
Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.
1,234,567.00 € 1,234,567.00 € (Tax excluded)

0.00 € / Units
Add to cart
Buy now
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Contact Us

Internal Reference: GMA-TNFRSF9
Display Name: [GMA-TNFRSF9] Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody